loteprednol etabonate · Bausch And Lomb · NDA 020583, 020841, 200738, 202872
Lotemax
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020583 · 001 · RLD | suspension/drops, ophthalmic | 0.5% | open |
| 020841 · 001 · discontinued | suspension/drops, ophthalmic | 0.5% | open |
| 200738 · 001 · RLD | ointment, ophthalmic | 0.5% | open |
| 202872 · 001 · RLD | gel, ophthalmic | 0.5% | open |